BI Asset Management Fondsmaeglerselskab’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.5M | Sell |
64,291
-461
| -0.7% | -$171K | 0.19% | 96 |
|
|
2026
Q1 | $16.6M | Sell |
64,752
-53,214
| -45% | -$17.5M | 0.17% | 109 |
|
|
2025
Q4 | $38.7M | Sell |
117,966
-27,442
| -19% | -$9.27M | 0.34% | 60 |
|
|
2025
Q3 | $44.4M | Buy |
145,408
+15,294
| +12% | +$4.76M | 0.4% | 53 |
|
|
2025
Q2 | $47.9M | Buy |
130,114
+5,027
| +4% | +$2.02M | 0.47% | 47 |
|
|
2025
Q1 | $54.4M | Buy |
125,087
+9,511
| +8% | +$3.82M | 0.61% | 31 |
|
|
2024
Q4 | $42.6M | Buy |
+115,576
| New | +$48.4M | 0.45% | 41 |
|
|
2024
Q3 | – | Sell |
-96,622
| Closed | -$52.4M | – | 632 |
|
|
2024
Q2 | $52.4M | Buy |
96,622
+9,255
| +11% | +$4.89M | 0.86% | 21 |
|
|
2024
Q1 | $45.3M | Buy |
87,367
+18,133
| +26% | +$9.02M | 0.85% | 27 |
|
|
2023
Q4 | $32.6M | Sell |
69,234
-4,743
| -6% | -$2.19M | 0.69% | 31 |
|
|
2023
Q3 | $32.2M | Buy |
73,977
+3,648
| +5% | +$1.65M | 0.75% | 30 |
|
|
2023
Q2 | $31.2M | Sell |
70,329
-12,642
| -15% | -$5.83M | 0.74% | 34 |
|
|
2023
Q1 | $38.2M | Buy |
82,971
+1,001
| +1% | +$476K | 1.01% | 18 |
|
|
2022
Q4 | $42M | Buy |
81,970
+6,009
| +8% | +$3.05M | 1.12% | 18 |
|
|
2022
Q3 | $34.5M | Buy |
75,961
+6,648
| +10% | +$3.18M | 1.76% | 14 |
|
|
2022
Q2 | $33.4M | Sell |
69,313
-11,978
| -15% | -$5.93M | 1.43% | 15 |
|
|
2022
Q1 | $39.9M | Buy |
81,291
+10,112
| +14% | +$4.62M | 1.53% | 10 |
|
|
2021
Q4 | $33M | Sell |
71,179
-7,406
| -9% | -$3.12M | 1.22% | 17 |
|
|
2021
Q3 | $29.3M | Sell |
78,585
-6,552
| -8% | -$2.49M | 1.11% | 21 |
|
|
2021
Q2 | $32.5M | Sell |
85,137
-6,078
| -7% | -$2.32M | 1.25% | 18 |
|
|
2021
Q1 | $32.7M | Sell |
91,215
-24,819
| -21% | -$7.98M | 1.33% | 15 |
|
|
2020
Q4 | $37.3M | Sell |
116,034
-9,920
| -8% | -$3.04M | 1.62% | 15 |
|
|
2020
Q3 | $33.8M | Buy |
125,954
+18,012
| +17% | +$4.85M | 1.54% | 11 |
|
|
2020
Q2 | $28.4M | Buy |
107,942
+890
| +0.8% | +$237K | 1.46% | 17 |
|
|
2020
Q1 | $24.3M | Buy |
107,052
+6,767
| +7% | +$1.84M | 1.44% | 24 |
|
|
2019
Q4 | $30.3M | Sell |
100,285
-6,130
| -6% | -$1.69M | 1.43% | 26 |
|
|
2019
Q3 | $25.6M | Buy |
106,415
+10,738
| +11% | +$2.94M | 1.26% | 32 |
|
|
2019
Q2 | $27M | Buy |
95,677
+9,477
| +11% | +$2.59M | 1.28% | 36 |
|
|
2019
Q1 | $24.7M | Buy |
86,200
+25,099
| +41% | +$7.26M | 1.24% | 40 |
|
|
2018
Q4 | $16M | Sell |
61,101
-700
| -1% | -$192K | 1.03% | 48 |
|
|
2018
Q3 | $16.9M | Buy |
61,801
+9,000
| +17% | +$2.34M | 1.06% | 40 |
|
|
2018
Q2 | $12.6M | Sell |
52,801
-2,861
| -5% | -$663K | 0.9% | 48 |
|
|
2018
Q1 | $12.2M | Sell |
55,662
-18,500
| -25% | -$4.35M | 0.94% | 47 |
|
|
2017
Q4 | $16.7M | Buy |
74,162
+4,700
| +7% | +$1M | 1.25% | 30 |
|
|
2017
Q3 | $13.2M | Buy |
69,462
+3,500
| +5% | +$666K | 0.99% | 37 |
|
|
2017
Q2 | $12.4M | Sell |
65,962
-29,500
| -31% | -$5.3M | 0.93% | 36 |
|
|
2017
Q1 | $15.8M | Buy |
95,462
+2,700
| +3% | +$429K | 1.14% | 26 |
|
|
2016
Q4 | $13.3M | Sell |
92,762
-7,000
| -7% | -$937K | 1.05% | 28 |
|
|
2016
Q3 | $12.5M | Buy |
99,762
+5,500
| +6% | +$710K | 1.05% | 28 |
|
|
2016
Q2 | $12.4M | Buy |
94,262
+13,400
| +17% | +$1.83M | 1.14% | 28 |
|
|
2016
Q1 | $11.2M | Buy |
80,862
+9,500
| +13% | +$1.27M | 0.85% | 33 |
|
|
2015
Q4 | $9.95M | Buy |
+71,362
| New | +$9.83M | 0.79% | 36 |
|
Other funds holding ELV
BI Asset Management Fondsmaeglerselskab's ELV Position: Q2 2026 in Review
BI Asset Management Fondsmaeglerselskab reduced its Elevance Health (ELV) stake by 0.71% in Q2 2026, selling an estimated $171K and leaving 64,291 shares worth $23.5M. The position accounts for 0.19% of the portfolio, ranked #96.
BI Asset Management Fondsmaeglerselskab first reported a position in ELV in Q4 2015 and has held it in 42 quarters since. The position peaked at $54.4M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab held 64,291 shares of Elevance Health worth $23.5M as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab sold 461 Elevance Health shares in Q2 2026, an estimated $171K.
- Elevance Health made up 0.19% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #96 holding.
- BI Asset Management Fondsmaeglerselskab first reported a position in Elevance Health in Q4 2015 and has held it in 42 quarters since.
- BI Asset Management Fondsmaeglerselskab's Elevance Health position peaked at $54.4M in Q1 2025.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.